Inflammatory Bowel Disease Treatment

• Business
• Environment
• Financial
• France
• Healthcare
• Industrial
• Investment
• Management
• News
• Pharma & Biotech
• Science

Sanofi and Teva Collaborate on Inflammatory Bowel Disease Treatment, TEV’574, in $1.5 Billion Deal

(IN BRIEF) Sanofi and Teva Pharmaceuticals have announced a collaboration to co-develop and co-commercialize TEV’574, a promising asset currently in…